Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwell

Showing results (691-700 of 706) with videos related to

Pageof 71
Sort By:
Journal of Medicinal Chemistry|May 4, 2012
Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureasVibha Oza, Susan Ashwell, Lynsie Almeida, et al.
Annals of Nutrition & Metabolism|June 9, 2012
Documentation of functional and clinical effects of infant nutrition: setting the scene for COMMENTBerthold Koletzko, Hania Szajewska, Margaret Ashwell, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2008
Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitorsJames W Janetka, Lynsie Almeida, Susan Ashwell, et al.
Molecular Cancer Therapeutics|September 16, 2008
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapiesSonya D Zabludoff, Chun Deng, Michael R Grondine, et al.
European Journal of Nutrition|May 28, 2008
Current micronutrient recommendations in Europe: towards understanding their differences and similaritiesEsmée L Doets, Liesbeth S de Wit, Rosalie A M Dhonukshe-Rutten, et al.
European Journal of Nutrition|May 28, 2008
How we will produce the evidence-based EURRECA toolkit to support nutrition and food policyMargaret Ashwell, Janet P Lambert, Martine S Alles, et al.
Journal of Medicinal Chemistry|July 10, 2023
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, Jeremy Greenwood, Samantha Carriero, et al.
Journal of Medicinal Chemistry|June 15, 2019
Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) InhibitorsJian Lin, Wei Lu, Justin A Caravella, et al.
The British Journal of Nutrition|December 8, 2010
Proceedings of the Rank Forum on Vitamin DS A Lanham-New, J L Buttriss, L M Miles, et al.
Journal of Medicinal Chemistry|April 27, 2012
Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitorsMark A Ashwell, Jean-Marc Lapierre, Christopher Brassard, et al.
Pageof 71

Showing results (691-700 of 706) with videos related to

Sort By:
Pageof 71
Journal of Medicinal Chemistry|May 4, 2012
Discovery of checkpoint kinase inhibitor (S)-5-(3-fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide (AZD7762) by structure-based design and optimization of thiophenecarboxamide ureasVibha Oza, Susan Ashwell, Lynsie Almeida, et al.
Annals of Nutrition & Metabolism|June 9, 2012
Documentation of functional and clinical effects of infant nutrition: setting the scene for COMMENTBerthold Koletzko, Hania Szajewska, Margaret Ashwell, et al.
Bioorganic & Medicinal Chemistry Letters|June 13, 2008
Discovery of a novel class of 2-ureido thiophene carboxamide checkpoint kinase inhibitorsJames W Janetka, Lynsie Almeida, Susan Ashwell, et al.
Molecular Cancer Therapeutics|September 16, 2008
AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapiesSonya D Zabludoff, Chun Deng, Michael R Grondine, et al.
European Journal of Nutrition|May 28, 2008
Current micronutrient recommendations in Europe: towards understanding their differences and similaritiesEsmée L Doets, Liesbeth S de Wit, Rosalie A M Dhonukshe-Rutten, et al.
European Journal of Nutrition|May 28, 2008
How we will produce the evidence-based EURRECA toolkit to support nutrition and food policyMargaret Ashwell, Janet P Lambert, Martine S Alles, et al.
Journal of Medicinal Chemistry|July 10, 2023
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279Silvana Leit, Jeremy Greenwood, Samantha Carriero, et al.
Journal of Medicinal Chemistry|June 15, 2019
Discovery and Optimization of Quinolinone Derivatives as Potent, Selective, and Orally Bioavailable Mutant Isocitrate Dehydrogenase 1 (mIDH1) InhibitorsJian Lin, Wei Lu, Justin A Caravella, et al.
The British Journal of Nutrition|December 8, 2010
Proceedings of the Rank Forum on Vitamin DS A Lanham-New, J L Buttriss, L M Miles, et al.
Journal of Medicinal Chemistry|April 27, 2012
Discovery and optimization of a series of 3-(3-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amines: orally bioavailable, selective, and potent ATP-independent Akt inhibitorsMark A Ashwell, Jean-Marc Lapierre, Christopher Brassard, et al.
Pageof 71